IMA is loading

Main Financial Data 2005

Main Data: 31/12 Year 2005
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 398.79
– gross margin 156.39
– total operating cost 117.33
– net operating profit 35.58
– financial expenses, net 7.54
– net income before taxes 12.46

 

Consolidated balance sheet Millions/Euro
– operating capital 77.40
– fixed assets, net 133.57
– reserves and MLT non financial payables -29.07
– net financial position -86.84
– stockholders’ equity 95.06

 

Other information Millions/Euro
– depreciation 13.61
– R & D expenses 18.27

 

  Euro
Dividend per share 0.40

 

  No.
Employees 2,686

 

  Euro
Shares outstanding 18,772,000

 

Main Data: 30/06 Year 2005
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 156.5
– gross margin 58.9
– total operating cost 57.6
– net operating profit 1.3
– financial expenses, net 3.2
– net income before taxes -1.1

 

Consolidated balance sheet Millions/Euro
– operating capital 82.6
– fixed assets, net 132.0
– reserves and MLT non financial payables -30.5
– net financial position -101.8
– stockholders’ equity 82.3

 

Other information Millions/Euro
– depreciation 5.2
– R & D expenses 9.3

 

  No.
Employees 2,617

 

  Euro
Shares outstanding 18,772,000

 

Net sales by sector: Year 2005
  Millions/Euro  
tea, herbs & coffee 70.88 17.77%
pharmaceuticals packaging 223.43 56.03%
pharmaceuticals processing 104.48 26.20%
Total 398.79 100.00%

 

Net Sales by Country: Year 2005
  Millions/Euro  
E.U. (excluding Italy) 156.51 39.25%
Other European countries 31.38 7.87%
North America 86.25 21.63%
Asia & Middle East 50.28 12.61%
Other countries 35.77 8.97%
Total exports 360.19 90.32%
Italy 38.60 9.68%
Total 398.79 100.00%
Dismissclose

IMA Pharma
@ Achema

Explore the dedicated website and get a free entry pass with IMA